Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

NCT05133609 is registered in ClinicalTrials.gov with Federal University of Espirito Santo as lead sponsor.

NCT NCT05133609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05133609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 VACCINE SAFETY AND EFFECTIVENESS
Lead sponsor
Federal University of Espirito Santo
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 15, 2021
Completion date
December 30, 2023
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection